"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"

Email Contact
reason -at- fightaging -dot- org

  
Search

The Causes of Aging
Accumulating AGEs
Buildup of Amyloid Between Cells
The Failing Immune System
Declining Lysosomal Function
Mitochondrial DNA Damage
Senescent Cells
Other Causes of Aging

Required Reading
Calorie Restriction
The Community, Visualized
Cryonics
Engineered Negligible Senescence
Envisaging a World Without the FDA
Healthy Life Extension Explained
Introductory Articles
Longevity Meme Newsletter
The Odds of Human Longevity Mutations
The Need For Activism and Advocacy
Stem Cells, Regenerative Medicine
Twelve Ways to Extend Mouse Life Span
The Vital Debate in Aging Research
What is Anti-Aging?

Initiatives
Biogerontology Research Foundation
Campaign Against Aging
Campaign for Aging Research
LifeStar Institute
Immortality Institute
Maximum Life Foundation
Methuselah Foundation
Mprize for Longevity Research
Science Against Aging (Translate)
SENS Foundation

Benefiting From Medical Research
How to Read Scientific Research
Researching Therapies and Clinical Trials

Objections Answered
Boredom
Inequality and Economics
Overpopulation
Stagnation
Being Older for Longer?
What About Retirement?

Recent Entries

  • The Conservative View of Progress in Applied Cancer Research
  • More on Stem Cell Technology and the Rise of Medical Tourism
  • Resting Metabolic Rate and Aging, Another of Metabolism's Complexities
  • Capabilities in Stem Cell Science Are Advancing Rapidly
  • Incentives and Cryonics
  • Videos From the Foresight 2010 Conference
  • A Steady Flow of New Donors at the Methuselah Foundation
  • Manipulating Fat in the Context of Slowing Aging
  • On Medical Tourism For Stem Cell Therapies
  • Cells, Hearts, and Brains
  • Rapamycin Research Rolls Onward
  • Reversing Blindness in Retinitis Pigmentosa With Stem Cells
  • The Body Does Work to Break Down Damaging Aggregates
  • A Few Cancer Stem Cell Articles
  • The Latest on Mitochondrial Uncoupling
  • Longevity Research at the Science Network
  • Journalists Are In the Business of Gathering Eyeballs, Not Truth
  • @ging, a New Aging Science Blog
  • Redefining Bionics Again
  • Encouraging Transparency in Life Science Fundraising

    Blogs of Interest
    @ging
    Accelerating Future
    Ageing Research
    Alcor News
    Al Fin Longevity
    April's CR Diary
    Andart
    Biology of Aging
    Biosingularity
    CRON Diary
    Cryonics Society
    Depressed Metabolism
    Distributed Republic
    Ethical Technology Blog
    Existence is Wonderful
    Foresight Institute
    Future Current
    FuturePundit
    grailsearch.org
    green light go
    HumanPlus
    In Search of Enlightenment
    Marginal Revolution
    Maximum Life Foundation Blog
    Metamagician and the Hellfire Club
    Metamodern
    Methuselah Foundation Blog
    Mises Economics Blog
    Ouroboros
    Overcoming Bias
    Pimm - Partial immortalization
    Responsible Nanotechnology
    ScienceBlogs
    Sentient Developments
    Singularity Hub
    Singularity Institute Blog
    Sonia Arrison
    The Speculist
    The Technological Citizen

    Archives (Monthly)

    March 2010
    February 2010
    January 2010
    December 2009
    November 2009
    October 2009
    September 2009
    August 2009
    July 2009
    June 2009
    May 2009
    April 2009
    March 2009
    February 2009
    January 2009
    December 2008
    November 2008
    October 2008
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    March 2008
    February 2008
    January 2008
    December 2007
    November 2007
    October 2007
    September 2007
    August 2007
    July 2007
    June 2007
    May 2007
    April 2007
    March 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006
    September 2006
    August 2006
    July 2006
    June 2006
    May 2006
    April 2006
    March 2006
    February 2006
    January 2006
    December 2005
    November 2005
    October 2005
    September 2005
    August 2005
    July 2005
    June 2005
    May 2005
    April 2005
    March 2005
    February 2005
    January 2005
    December 2004
    November 2004
    October 2004
    September 2004
    August 2004
    July 2004
    June 2004
    May 2004
    April 2004
    March 2004
    February 2004
    January 2004

    Creative Commons

    Creative Commons License

    Fight Aging! is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.

  • Monday, November 20, 2006

    Recent Alzheimer's Research

    To follow up on comments on the culture of Alzheimer's research linked over at the Longevity Meme, I thought I'd point out some of the folk working hard to inject new ideas and theories into the field. You don't have to look far; quite a few interesting lines of research have reached the popular science websites in just the past few days:

    Alzheimer's heart link explained:

    Scientists have discovered how heart disease or a stroke may trigger Alzheimer's disease. Both conditions lead to a reduction of oxygen flow to the brain. A University of British Columbia team, studying mice, found this stimulates increased development of the protein clumps thought to cause Alzheimer's.

    ...

    Scientists have known for some time that people with certain diseases that restrict their supply of oxygen, such as stroke or lung disorders, are more prone to Alzheimer's and also that people who live at high altitudes are also at greater risk of developing the disease. This research provides a molecular explanation for that anecdotal finding and shows that cues from cells, genes and a person's environment all play a role in causing this dreadful disease.

    Nerve Fibers Need Specific Growth Factor Chemical To Form Connections Within The Brain:

    The study uncovers how cholinergic neuronal circuits, which help the cerebral cortex process information more efficiently, rely on neurotrophin-3, a chemical that stimulates nerve growth. The scientists have determined the circuits need this chemical in order to recognize and reach their target nerve cells in the brain.

    ...

    This finding, according to Robertson, has significant implications for neurodegenerative diseases like Alzheimer’s. Cholinergic neuronal circuits play a key role in the proper information processing by the cerebral cortex and other areas of the brain. The cerebral cortex is the part of the brain that determines intelligence, personality, and planning and organization, and these actions are compromised by neurodegenerative diseases.

    “Studies on the brains of Alzheimer’s patients have shown a marked decline in these cholinergic circuits. Our work demonstrates that neurotrophin-3 is essential to maintain the connections to cerebral cortex neurons,” Robertson said. “This study shows that a neurotrophin-3 therapy may be able to induce nerve fibers to regrow in the cerebral cortex, which would be beneficial to people with Alzheimer’s.”

    More insight into Alzheimer's disease with Stanford discovery of possible cause:

    A peacekeeper in the body's defenses against infection may hold the key to understanding - and eventually treating - Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease.

    ...

    Wyss-Coray and Ina Tesseur, PhD, an instructor in the Department of Neurology, examined thin slices of the brains of Alzheimer's patients who had died, and discovered abnormally low levels of a molecule involved in controlling the body's response to infection. That molecule allows the brain to detect and respond to TGF-beta, or transforming growth factor, a protein teeming through our bodies, involved in fighting infection, stopping cancer and perhaps keeping brain cells alive.

    No other researchers had seen this change before, so Tesseur and Wyss-Coray set out to investigate whether it had some connection to Alzheimer's disease. They hypothesized that by protecting neurons, TGF-beta may help prevent Alzheimer's disease. If the TGF-beta pathway is turned off, the brain becomes more susceptible to a toxic buildup of proteins.

    The problem with Alzheimer's - and most other complex biochemistry - is the matter of identifying what is the cause and what is the effect. It is to be expected that much of what has been discovered by researchers will fall to the wayside as a side-effect of the progression of Alzheimer's rather than an actual root cause. Equally, most of the therapies currently under development will turn out to be largely ineffective patching up of consequences rather than cures. Such is the way we forge into the unknown; understanding will come, as the scientific method is a powerful filter for effective solutions to any problem.

    Is Alzheimer's actually a form of diabetes at root? Is it a failure of amyloid clearing mechanisms? Is amyloid even a cause, or is it a giant red herring and consequence of the real underlying biochemistry of the condition? It's a complex business - new ideas and broader exploration are certainly needed while the establishment forges ahead with consensus work on understanding and defeating the buildup of amyloid.

    Technorati tags: , ,

    Posted by Reason

     
    Share |

    Posted by: anonymous at November 21, 2006 8:32 AM

    I wish people were more careful using the term "Alzheimers", because that disease clearly has a genetic component and tends to strike people before they are 65 years of age. The kind of dementia being discussed in the article is clearly circulatory in nature, and should be called "circulatory dementia", not "Alzheimers". The reason for this is simple and should be obvious: persons with the Alzheimers gene(s) are much more likely to get the illness than any randomly selected person. There may be some interventions short of modifying their genotype that can reduce the probability, or delay the onset, but really in the end they need their genes "fixed".

    Circulatory dementia, on the other hand, is likely a function of any of several circulatory problems, starting with high blood pressure & all the things that associate with it. As noted, it may be tied to diabetes (which affects blood pressure), it may be driven by plaque in arteries, etc. but we can intervene against it the same way we go after athlersclerosis.

    Thus we have two categories of "Alzheimers", one genetic, one arguably preventable via some other means. That's not very good taxonomy! It leads to thinking in the wrong directions.

    So let's call dementia induced by circulatory problems "circulatory dementia" or "dementia", not "Alzheimers". In this world of fuzzy terms, we need to use accurate and sharp words that convey an accurate meaning.

    And thanks for the roundup on this topic.

    [Posted by: anonymous at November 21, 2006 8:32 AM]

    Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.










    Remember personal info?